Allo-reactive T cells for the treatment of hematological malignancies
Allo-reactive T cells for the treatment of hematological malignancies
About this item
Full title
Author / Creator
Publisher
United States: Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier B.V
Subjects
More information
Scope and Contents
Contents
Several mechanisms can be responsible for control of hematological tumors by allo-reactive T cells. Following allogeneic stem cell transplantation (alloSCT) donor T cells recognizing genetic disparities presented on recipient cells and not on donor cells are main effectors of tumor control, but also of the detrimental graft versus host disease (GVH...
Alternative Titles
Full title
Allo-reactive T cells for the treatment of hematological malignancies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5528734
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5528734
Other Identifiers
ISSN
1574-7891
E-ISSN
1878-0261
DOI
10.1016/j.molonc.2015.10.014
